Gilead Sciences : GILD

All Gilead Sciences Articles

730 Articles

Paul Ausick | Feb 9, 2017 at 4:04 PM EST

Vista Outdoor, Fossil Group Dive into Thursday’s 52-Week Low Club

Vista Outdoor, Gilead Sciences, Fitbit, and Fossil posted new 52-week lows on Thursday.

Paul Ausick | Feb 8, 2017 at 4:08 PM EST

Gilead Sciences, Fitbit Plunge into Wednesday’s 52-Week Low Club

Gilead Sciences, Gale Biopharma, Teva, and Fitbit post new 52-week lows Wednesday.

Chris Lange | Feb 8, 2017 at 12:35 PM EST

What Analysts Are Saying About Gilead Sciences After Earnings

24/7 Wall St. has included some highlights from the Gilead Sciences earnings report, as well as what analysts are saying…

Chris Lange | Feb 8, 2017 at 11:35 AM EST

Wednesday’s Biggest Biopharma Movers

Not that many biotech and pharma companies were on the move Wednesday, but a few of the smaller caps made…

Jon C. Ogg | Feb 8, 2017 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Broadcom, Cheniere, Gilead, Microchip Tech, Twitter, Lennar, Bankrate and Many More

The op analyst upgrades, downgrades and initiations seen on Wednesday include Broadcom, Cheniere Energy, Gilead Sciences, Microchip Technology, Twitter, Lennar…

Chris Lange | Feb 7, 2017 at 4:20 PM EST

Why Gilead Earnings Were Not Up to Snuff

Gilead Sciences Inc. (NASDAQ: GILD) reported its fourth-quarter earnings after the markets closed on Tuesday. The company posted $2.70 in…

Chris Lange | Feb 7, 2017 at 10:10 AM EST

What to Expect From Gilead Earnings

Gilead Sciences is set to report its fourth-quarter financial results after the markets close on Tuesday.

Chris Lange | Feb 5, 2017 at 10:25 AM EST

Top 7 Earnings for the Week Ahead

24/7 Wall St. has put together a preview of GM, Twitter, NVIDIA and some of the major companies reporting their…

Jon C. Ogg | Feb 2, 2017 at 8:10 AM EST

7 Dirt Cheap S&P 500 Value Stocks for Massive Upside Potential for 2017 and 2018

With stocks at all-time highs, perhaps there may be some better safety in companies that are known and that offer…

Chris Lange | Jan 26, 2017 at 10:35 AM EST

Short Sellers Back Off Major Biotechs

As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears…

Paul Ausick | Jan 24, 2017 at 4:01 PM EST

Gilead Sciences, DryShips Stuck in Tuesday’s 52-Week Low Club

DryShips, Gilead Sciences, BT Group, and Cascadian Therapeutics made new 52-week lows on Tuesday.

Paul Ausick | Jan 23, 2017 at 4:04 PM EST

Teva, Gilead Sciences Tumble into Monday’s 52-Week Low Club

DryShips, Teva, Endo Pharma, and Gilead Sciences posted new 52-week lows Monday.

Lee Jackson | Jan 23, 2017 at 9:55 AM EST

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

A new Jefferies research report makes the case that while market parameters are indeed expensive, there still are cheap stocks…

Chris Lange | Jan 12, 2017 at 9:35 AM EST

Biotech Short Sellers Run for Cover

As we have approached Trump’s inauguration, the health care sector in general has rallied. Now it’s time to see what…

Lee Jackson | Jan 10, 2017 at 8:35 AM EST

Jefferies Has 5 Top Biotech Stocks to Buy for 2017

Needless to say, the past two years have been rough on biotech. The question for investors is which of the…

1 … 21 22 23 24 25 … 49

Gilead Sciences : GILD

All Gilead Sciences Articles

Vista Outdoor, Fossil Group Dive into Thursday’s 52-Week Low Club

Gilead Sciences, Fitbit Plunge into Wednesday’s 52-Week Low Club

What Analysts Are Saying About Gilead Sciences After Earnings

Wednesday’s Biggest Biopharma Movers

Top Analyst Upgrades and Downgrades: Broadcom, Cheniere, Gilead, Microchip Tech, Twitter, Lennar, Bankrate and Many More

Why Gilead Earnings Were Not Up to Snuff

What to Expect From Gilead Earnings

Top 7 Earnings for the Week Ahead

7 Dirt Cheap S&P 500 Value Stocks for Massive Upside Potential for 2017 and 2018

Short Sellers Back Off Major Biotechs

Gilead Sciences, DryShips Stuck in Tuesday’s 52-Week Low Club

Teva, Gilead Sciences Tumble into Monday’s 52-Week Low Club

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

Biotech Short Sellers Run for Cover

Jefferies Has 5 Top Biotech Stocks to Buy for 2017

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Gilead Sciences : GILD

All Gilead Sciences Articles

Vista Outdoor, Fossil Group Dive into Thursday’s 52-Week Low Club

Gilead Sciences, Fitbit Plunge into Wednesday’s 52-Week Low Club

What Analysts Are Saying About Gilead Sciences After Earnings

Wednesday’s Biggest Biopharma Movers

Top Analyst Upgrades and Downgrades: Broadcom, Cheniere, Gilead, Microchip Tech, Twitter, Lennar, Bankrate and Many More

Why Gilead Earnings Were Not Up to Snuff

What to Expect From Gilead Earnings

Top 7 Earnings for the Week Ahead

7 Dirt Cheap S&P 500 Value Stocks for Massive Upside Potential for 2017 and 2018

Short Sellers Back Off Major Biotechs

Gilead Sciences, DryShips Stuck in Tuesday’s 52-Week Low Club

Teva, Gilead Sciences Tumble into Monday’s 52-Week Low Club

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

Biotech Short Sellers Run for Cover

Jefferies Has 5 Top Biotech Stocks to Buy for 2017

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%